E. A. Aiello Bowles

发表

Nurse navigators in early cancer care: a randomized, controlled trial.

Robert B. Penfold, R. Reid, E. Wagner, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of antidepressants after colon cancer diagnosis and risk of recurrence

A. Sterrett, R. Hubbard, D. Boudreau, 2019, Psycho-oncology.

Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

D. Buist, D. Boudreau, M. Fujii, 2012, Journal of oncology practice.

Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system

R. Reid, E. Wagner, C. Rutter, 2014, Journal of Cancer Survivorship.

Reply: To PMID 23490543.

H. Feigelson, A. Onitilo, J. Engel, 2013, Journal of the American College of Surgeons.

Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database

A. Sterrett, H. Feigelson, A. Onitilo, 2012, BMC Cancer.

Gretchen L. Gierach, H. Feigelson, D. Buist, 2022, The Lancet. Oncology.

Changes in use of opioid therapy after colon cancer diagnosis: a population-based study

A. Sterrett, R. Hubbard, D. Boudreau, 2019, Cancer Causes & Control.

Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.

A. LaCroix, P. Crane, E. Larson, 2019, Journal of Alzheimer's disease : JAD.

Radiologists' attitudes and use of mammography audit reports.

J. Elmore, D. Miglioretti, K. Kerlikowske, 2010, Academic radiology.

Variability in reexcision following breast conservation surgery.

H. Feigelson, A. Onitilo, J. Engel, 2012, JAMA.

Circulating serum xenoestrogens and mammographic breast density

E. Burnside, D. Buist, A. Trentham-Dietz, 2013, Breast Cancer Research.

Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency

D. Miglioretti, R. Hubbard, K. Kerlikowske, 2023, JAMA network open.

Trends in Medical Imaging During Pregnancy in the United States and Ontario, Canada, 1996 to 2016

D. Miglioretti, R. Greenlee, R. Smith-Bindman, 2019, JAMA network open.

Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history

J. Elmore, D. Buist, Melissa L. Anderson, 2009, Breast Cancer Research and Treatment.

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.

Gretchen L. Gierach, R. Hoover, M. Sherman, 2015, Journal of the National Cancer Institute.

Proton Pump Inhibitor Use and Dementia Risk: Prospective Population‐Based Study

P. Crane, E. Larson, R. Walker, 2018, Journal of the American Geriatrics Society.

The quality of cancer patient experience: perspectives of patients, family members, providers and experts

Sarah M. Greene, Cheryl J Wiese, E. Wagner, 2010, Quality and Safety in Health Care.

Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer

H. Feigelson, A. Onitilo, J. Engel, 2013, PloS one.

Improving modern cancer care through information technology.

Sarah M. Greene, E. Wagner, S. Clauser, 2011, American journal of preventive medicine.

Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors.

Andrea J Cook, Gary R Cutter, Joann G Elmore, 2010, Journal of clinical epidemiology.

Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial

D. Buist, K. Newton, C. Landis, 2011, Menopause.

Short-term (1-2 mo) hormone therapy cessation before mammography

D. Buist, K. Newton, S. Reed, 2009, Menopause.

Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer

L. Allen, E. Wagner, A. Onitilo, 2014, Medical care.

Short-Term Hormone Therapy Suspension and Mammography Recall

D. Buist, K. Newton, S. Reed, 2009, Annals of Internal Medicine.

Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

D. Schrag, M. Hornbrook, J. Weeks, 2012, The Oncologist.

Anesthesia Exposure and Risk of Dementia and Alzheimer's Disease: A Prospective Study

P. Crane, E. Larson, R. Walker, 2016, Journal of the American Geriatrics Society.

Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States

C. Lehman, K. Newton, J. Lampe, 2009, Breast Cancer Research and Treatment.

Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Jennifer S. Lin, Paula R. Blasi, N. Henrikson, 2019, JAMA.

Radiologists' perceptions of computer aided detection versus double reading for mammography interpretation.

Karla Kerlikowske, Joann G Elmore, Tracy Onega, 2010, Academic radiology.

Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study.

H. Feigelson, A. Onitilo, T. James, 2013, Journal of the American College of Surgeons.

Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data.

H. Uno, A. Tosteson, D. Schrag, 2019, JCO clinical cancer informatics.

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Gretchen L. Gierach, R. Hoover, M. Sherman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

No Effect of Aspirin on Mammographic Density in a Randomized Controlled Clinical Trial

J. Potter, A. McTiernan, N. Urban, 2009, Cancer Epidemiology Biomarkers & Prevention.

Understanding high‐quality cancer care

Sarah M. Greene, Cheryl J Wiese, E. Wagner, 2008, Cancer.

Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer.

Nikki M. Carroll, M. Hornbrook, L. Kushi, 2015, Journal of oncology practice.

Validation of Electronic Data on Chemotherapy and Hormone Therapy Use in HMOs

Nikki M. Carroll, M. Hornbrook, P. Fishman, 2013, Medical care.

Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network.

Nikki M. Carroll, M. Hornbrook, L. Kushi, 2012, Lung cancer.

Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients

Gretchen L. Gierach, R. Hoover, M. Sherman, 2019, Journal of clinical medicine.

Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

D. Buist, T. Onega, Melissa L. Anderson, 2017, Preventive medicine.

The vitamin D pathway and mammographic breast density among postmenopausal women

E. Burnside, D. Buist, A. Trentham-Dietz, 2011, Breast Cancer Research and Treatment.

Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort

Gretchen L. Gierach, H. Feigelson, D. Buist, 2023, Breast Cancer Research.

Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women

K. Newton, S. Schwartz, W. Leisenring, 2006, Cancer Causes & Control.

Associations between Polymorphisms in Glucuronidation and Sulfation Enzymes and Mammographic Breast Density in Premenopausal Women in the United States

K. Newton, S. Schwartz, W. Leisenring, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Feasibility and satisfaction with a tailored web-based audit intervention for recalibrating radiologists' thresholds for conducting additional work-up.

J. Elmore, D. Miglioretti, S. Feig, 2011, Academic radiology.

Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension.

D. Buist, K. Newton, S. Reed, 2010, Journal of women's health.

Misclassification of Breast Imaging Reporting and Data System (BI‐RADS) Mammographic Density and Implications for Breast Density Reporting Legislation

D. Miglioretti, C. Rutter, S. Taplin, 2015, The breast journal.

Timing of follow-up after abnormal screening and diagnostic mammograms.

Karen J Wernli, Sebastien Haneuse, J. Elmore, 2011, The American journal of managed care.

Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

D. Schrag, M. Hornbrook, J. Weeks, 2012, The oncologist.

Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

D. Buist, T. Onega, Melissa L. Anderson, 2017, Preventive Medicine.

Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension.

D. Buist, K. Newton, D. Seger, 2010, Journal of women's health.

Best ways to provide feedback to radiologists on mammography performance.

B. Geller, E. A. Aiello Bowles, 2009, AJR. American journal of roentgenology.

Misclassification of Breast Imaging Reporting and Data System (BI‐RADS) Mammographic Density and Implications for Breast Density Reporting Legislation

D. Miglioretti, C. Rutter, S. Taplin, 2015, The breast journal.

Mammographic Breast Density and Serum Phytoestrogen Levels

E. Burnside, D. Buist, A. Trentham-Dietz, 2012, Nutrition and cancer.

Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study

D. Buist, E. A. Aiello Bowles, Emma C. Atakpa, 2023, Breast Cancer Research.